Analisi di costo-utilità di evolocumab in pazienti con ASCVD in Italia

OBJECTIVE: The aim of this work was to evaluate the cost-effectiveness of evolocumab in addition to standard statin therapy with or without ezetimibe in the treatment of patients with clinically evident atherosclerotic cardiovascular disease (ASCVD) with levels of LDL-C above 100 mg/dL. METHOD: A th...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcellusi, Andrea, Bini, Chiara, Rotundo, Maria Assunta, Arcangeli, Emanuela, Martinez, Laura, Vilela, Francesc Sorio, Mennini, Francesco Saverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ORIGINAL RESEARCH ARTICLE 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616188/
https://www.ncbi.nlm.nih.gov/pubmed/36627880
http://dx.doi.org/10.33393/grhta.2021.2255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616188/
https://www.ncbi.nlm.nih.gov/pubmed/36627880
http://dx.doi.org/10.33393/grhta.2021.2255

Ejemplares similares